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Chinese herbal drugs have been proved to be effective agents in myocardial protection
by preventing ischemia-reperfusion injury. The underlying mechanisms as to how these agents
work were however poorly elucidated. Studies on the monomers or on the single drugs have
highlighted the possible rationales, leading to a better understanding of the pharmaceutical
effects of the active parts of the herbs. These agents have been found to be
structure-sensitive while they play the role of a protective ingredient. Polysaccharides
of Chinese herbal medicine have pharmaceutical effects in immune modulation,
anti-inflammation, anti-virus, anti-tumor, anti-aging mechanisms, with an anti-oxidative
effect being a commonly recognized mechanism. Saponins are prone to alleviate calcium
overload. As bioflavonoids commonly contain active phenolic hydroxy group, they have good
anti-oxidant property. Those containing effective lignanoids and essential oils can result
in a reduced nitric oxide secretion of the endothelial cells and an increased intercellular
cell adhesion molecule-1 expression. Alkaloids may resist free radical injuries. Most
importantly, modern in-depth research revealed that myocardial infarction is typically
associated with apoptosis, and herbal medicine containing carbohydrates and glycosides
showed cardioprotective effects by way of inhibiting apoptosis of myocytes. As a supplement
to cardioplegia, some Chinese herbal drugs have become especially valuable in myocardial
protection in open heart surgery by preserving metabolic energy. In conclusion, the
classification of Chinese herbal medicine made according to their main active ingredients
has facilitated the expression of their functioning mechanisms. Chinese herbal drugs play
an important role in cardioprotection via many different mechanisms, the most recent and
important finding being the inhibition of apoptosis.
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Introduction
Several theories, including calcium overload, oxygen free radicals, infiltration
of granular leukocytes, complement participation, enzymatic effects, apoptosis, and gene
expression disorder, etc., have been popularly recognized as the fundamental mechanisms
of myocardial injury due to ischemia-reperfusion(Wang and He, 2004. Alternative strategies
with the purpose of myocardial preservation therefore start with alleviation of calcium
overload, maintenance of homeostasis of the cellular membrane, inhibition of nitric oxide
(NO) delivery, and prevention of apoptosis. Recent studies discovered coagulable cytolysis
around the ischemic myocardial infarction zone without presence of infiltration of
inflammatory cells, a phenomenon similar to the morphological changes of apoptosis.
Accordingly, an agreement was reached that myocardial infarction was typically associated
with apoptosis. In a rabbit model of ischemia-reperfusion injury, scattered apoptotic cells
positive for terminal deoxynucleotidyl transferase dUTP nick end-labeling were present in
the ischemic region 1 hr after ischemia, peaked at 3 hrs, and decreased thereafter, whereas
no apoptotic cells were found in the normal myocardium. Furthermore, apoptotic cells began
to appear in the ischemic margin 1 hr after ischemia, and the number of the apoptotic cells
increased with time and peaked at 5 hrs after ischemia, suggesting apoptosis may be a main
feature of myocardial ischemia (Hu et al., 2001). It was shown that growth factors may inhibit
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the development of apoptosis and hence alleviate the apoptosis of myocytes caused by
ischemia-reperfusion injury. Like the growth factors, Chinese herbal drugs have gained a
popular recognition in terms of myocardial preservation by apoptotic inhibition (Zhang et
al., 2007).
Chinese herbal medicine was usually categorized with respect to Chinese medicinal
property or the natural character. With the introduction of modern scientific technologies,
novel classifications were introduced for Chinese medicine, such as drug effect, medicinal
portion, botanical, zoological, mineralogical, and chemical ingredient classifications.
Of them, the classification referring to the pertinent major active ingredients contained
in Chinese medicine is apparently convenient for the expression of their effective mechanisms.
In recent years, studies on these active ingredients of Chinese herbal drugs have become
attractive, leading to an in-depth understanding of the medicinal properties. These
ingredients were grouped into four classes: alkloids, flavonoids, saponins and others
including coumarins and lignanoids, that are related to vascular endothelial functions (Shi
and Yan, 2005). As for myocardial preservation, more components can be involved, such as




Radixes of Astragalus mongholicus Bge and Astragalus membranaceus Bge are quality
products of Astragalus mongholicus. The main components of Astragalus mongholicus include
Astragaloside, Astragalus polysaccharides, and flavonoids, etc. (Huo, 2007). Total
flavonoids of Astragulus could prevent the decrease of the NO concentration. Concomitantly,
total flavonoids of Astragulus and Astragaloside A work as inotropic agents by way of
increasing cAMP contents of the myocardium, and inhibiting the activity of the Na+-K+-ATPase
on the myocardial cellular membrane, while Astragalosides act as free radical scavengers.
Astragaloside IV is a leading active ingradient with inotropic effect, not only improving
heart function of the experimental rats, but also avoiding an increase of the oxygen
consumption of the myocardium (Fang, 2004). Total flavonoids of Astragulus may inhibit the
increase of the intracellular calcium concentration induced by isoproterenol hydrochloride,
indicating a calcium antagonism of the total flavonoids of Astragulus by relieving the calcium
overload of the sarcoplasmic reticulum (Meng et al., 2004). An increased superoxide dismutase
(SOD) and decreased malondialdehyde (MDA) and creatine phosphokinase (CPK) activities were
associated with the introduction of Astragalus mongholicus (Li et al., 2003). Additionally,
similar results for Astragalus mongholicus have been noted in patients with angina pectoris
(Li and He, 2003). Pretreatment with Astragalus membranaceus significantly attenuated the
daunorubicin-induced increases of reactive oxygen species, apoptosis and the secretions
of lactate dehydrogenase (LDH) in cultured neonatal cardiomyocytes of Sprague Dawley rats
(Luo et al., 2009). Astragalus mongholicus at a concentration of 100 g/L or 1000 g/L could
reduce the apoptotic rate by 34.96% and 37.02%, respectively. The upgrading of the reperfusion
injury salvage kinase (RISK), including PI3K-AKT and p42/44 [extracellular regulated protein
kinase (ERK)1/2] could be the initiating way of Astragalus mongholicusin to regulate
myocardial apoptosis. The mitogen-activated protein kinase signaling pathways have also
been found to be under the modulation of Astragalus mongholicus in the in vitro rabbit
ischemia-reperfusion injury and cultured myocyte hypoxia-reoxygenation models (Song et al.
2008).
1.2 Lycium bararum polysaccharides
The botanical source of Lycium bararum polysaccharides is the dry mature fruit of the
Solanaceae plant Lycium barbarum L. When Lycium Bararum Polysaccharide Extract was given
via gastric lavage or intraperitoneal injection to the animals, both lysozyme and SOD
activities and NO secretion were increased by resting macrophages, with the former drug
route having a better effect (Zhou et al., 2000). Lycium Bararum Polysaccharides can promote
the activities of glutathione peroxidase (GSH-Px) and SOD of the senile rats induced by
D-galactose, and can further scavenge the free radicals (Chen and Chen, 2005). When free
radical injuried myocytes induced by xanthine/xanthine oxidase system were treated by Lycium
Bararum Polysaccharides (12.5 μg/mL), the myocardial ultrastructures remained almost normal 
(Yang et al., 2001).
Yuan and Jing Afr J Tradit Complement Altern Med. (2011) 8(2):104-127 106
1.3 Tremella fucifamis Berte, or, Tremella fuciformispolysaccharide.
Tremella fucifamis Berte is a polysaccharide with free radical scavenging and
anti-lipid peroxidation effects. It is prepared and extracted from Tremella fucifamis by
submerged cultures. Tremella polysaccharide can protect cardiomyocytes by suppressing the
apoptosis induced by oxidative damage in vitro. The results suggested that Tremella tremella
polysaccharide had dose-related anti-apoptotic and anti-oxidative effects on cardiomyocytes
in D-galactose induced aging mice (Qu et al., 2009).
1.4 Saussures involucrate
The chemical ingredients isolated from Saussures involucrate have been proved to be
complex, including flavonoids, alkaloids, and polysaccharides, etc. The half-scavenging
concentration of polysaccharide of Saussurea was 22.0 μg/mL, with which the oxygen 
consumption of the mice could be reduced, and the swimming time of the animal increased.
Both hispidulin and acacetin that were isolated from Saussures involucrate were capable
of scavenging free radicals with anti-lipid peroxidation effect. The total alkaloids of
Saussures involucrate were able to decrease the permeability of the cutaneous vessels of
the rabbit, leading to a vascular contraction of the rabbit ear, which may be blocked by
α-antagonist regilin. Moreover, the total alkaloids of Saussures involucrate may slowdown
the heart rate or even heart arrest of the in vitro rabbit heart (Yuan et al., 2004).
1.5 Polysaccharide Krestin
Coriolus versicolor polysaccharide is an abstract of the dry carpophore of Polyporus
Varlus (PERS) Fr. Luo et al. (2002) administered the canine model of ischemia-reperfusion
injury with oral Polysaccharide Krestin 150 mg/kg daily two days prior to operation. They
found that these animals had better left ventricular ejection fraction and lower plasma
MDA contents during early reperfusion (5-120 mins).
2. Glycosides
2.1. Paenol
Paeonol is a main active ingredient of Cynanchum paniculatum (Bge.) Kitag. Paeonol
can decrease the cholesterol/phospholipid ratio of the mitochondrial membrane, and improve
membranous Ca2+-ATPase activity, membrane lipid fluidity and myocardial free fatty acid of
the myocardial ischemia-reperfusion injury model in mice (Zhang and Zhang, 1994). Tang and
Shi (1990) observed the Ca2+ influx in neonatal mice myocytes, a remarkable decrease in beating
rate of the myocytes, and an inhibition of the Ca2+ uptake in both fast and slow phases with
50-400 μg/mL paeonol. At a dose of 400 μg/mL, it showed a similar effect on the calcium 
uptake in cultured myocardial cells to verapamil at 10 μmol/L. 
2.2. Anthraglycosides and Quinones
2.2.1 Danshensu Salvianic acid A and Tanshinone
Danshensu Salvianic acid A showed its protective effect on myocardial mitochondria
of the ischemia-reperfusion injury mice by scavenging O- and OH-. Working as a free radical
scavenger to eradicate O-2, OH- and H2O2, sodium tanshinone IIA sulfonate (5 mg/kg) was able
to decrease the products of MDA in the myocardium and lessened the delivery of CPK. It
illustrated that as a free radical scavenger tanshinone was even superior to verapamil in
terms of myocardial protection in the in vitro mouse heart model. Experimental studies
disclosed that intravenous injection of sodium tanshinone IIA sulfonate in the canine
myocardial ischemia-reperfusion injury model may lead to decreased myocardial oxygen
consumption by lowering left ventricular wall stress, and brought about a decreased
myocardial infarcted area with an effect comparable to dipyridamole. Tanshinone IIA may
protect cultured PC12 cells from all injury models including hypoxia, hypoglucose, oxidant
injury, calcium overload, NO neurotoxicity, and glutamic acid injury, especially was good
for the ischemic and calcium overload injuries (He et al., 2001). In the myocardial infarction
rats, sodium tanshinone IIA sulfonate significantly reduced the infarct sizes, the blood
LDH level, and the number of apoptotic cardiomyocytes in the infarcted hearts (Yang et al.,
2008a). Protective mechanisms of tanshinone were evidenced to be mediated by increased
scavenging of oxygen free radicals, prevention of lipid peroxidation and upregulation of
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the Bcl-2/Bax ratio (Fu et al., 2007a). Tanshinone IIA may inhibit the increasing sizes
of the myocytes, the synthetic rate of the myocardial protein, and the apoptotic rate induced
by angiotensin II, thereby decreasing the expression of the apoptotic gene Fas mRNA (Feng
and Zheng, 2006). Tanshinone IIA (2 mmol/L) markedly attenuated adriamycin-induced reactive
oxygen species production, and prevented the adriamycin-mediated reduction of the Bcl-2/Bax
ratio as evidenced by the Western blot assay (Gao et al., 2008).
2.2.2 Polygonum multiflorum
Polygonum multiflorum is the dry radix of Polygonum multiflorum Thunb. It can improve
SOD activity of the myocytes, scavenge free radicals and inhibit lipid peroxidation.
Polygonum multiflorum may significantly improve the stability of the lysosomal membrane,
protect the membranal structure of the myocardium, and stabilize the cellular membrane (Jin
and Jin, 2006). Experiemntal studies revealed that Polygonum multiflorum inhibited 52.1
± 7.3% of the oxygen consumption and 50.9 ± 5.3% of MDA production (Hong et al., 1994).
Its ability to enhance myocardial anti-oxidant status under the conditions of ischemia
reperfusion-induced oxidative stress has been proved (Yim et al, 2000).
Tetrahydroxystilbene-glucoside, one of the effective ingredients of Polygonum multiflorum,
was tested in terms of its protective effect on rat myocardial ultrastructure.
Tetrahydroxystilbene-glucoside even in a low dose could remarkably decrease the expression
of transforming growth factor-β1 of myocardial cytoplasm, indicating a possible inhibition
on the transforming growth factor. Lower MDA levels and inducible nitric oxide synthase
(iNOS) activities of the myocytes were seen in the rats administered with
tetrahydroxystilbene-glucoside (Tang, 2006).
2.3. Flavonoids and Flavonoid glycosides
2.3.1 Ginkgo biloba extract (Egb761)
Egb761 is composed of flavonoids, terpenoids, phenolic compound, and amino acids, etc.
Liebgott et al. (2000) reported two main components of Egb761, flavonoid glycosides and
terpenoid, may coordinate scavenging free radicals and prevent peroxidation injury. Tosaki
et al. (1994) found EGb761 at a dose of 50 mg/kg or 100 mg/kg may significantly improve
coronary flow, aortic flow, left ventricular developed pressure, and the first derivative
of left ventricular developed pressure (dp/dt max). EGb761 can increase SOD activity of
the cytosol, prevent mitochondrial lipid peroxidation, maintain the Ca2+-ATPase activity
of the mitochondrial membrane, and improve Ca2+ transport of the ischemic myocardium (Li
et al., 2007a). Shen and Zhou (1995) found that EGb761 treatment (10 mg/kg, injected into
the coronary artery) resulted in significant inhibition of the lipid peroxidation and
preservation of total and CuZn-SOD levels in both plasma and the myocardium during and at
the end of reperfusion. Both tissue type plasminogen activator (t-PA) decrease and
plasminogen activator inhibitor-1 (PAI-1) increase mediated by ischemia-reperfusion were
significantly suppressed by EGb761. Egb761 can apparently alleviate the accumulation of
Na+ and Ca2+ and the loss of K+ and Mg2+ in the ischemia-reperfusion myocardium (Deng et al.,
2006). EGb761 could inhibit influx of excellular calcium of myocardium of neonatal rats
(Zhang et al., 2000). Egb761 along with its monomer Quercetin dihydrate may inhibit myocyte
hypertrophy, total protein and diameter increment, induced by angiotensin II, which could
thereby promote SOD activity and decrease MDA content (Wu and Gu, 2006). Egb761 has shown
an antagonistic action on platelet-activating factor, a key point of myocardial injury (Zhang
and Gao, 2008). Expressions of p-ERK1/2, p-JNK and p-P38 mediated by angiotensin II increased
significantly and Quercetin could apparently inhibit these expressions probably by the
ROS/JNK signaling pathway. In the Egb761-treated rats, apoptosis of the cardiomyocytes
decreased significantly, suggesting the protective effects of Egb761 on rat cardiomyocytes
against apoptosis (Yu et al., 2007). EGb761 could typically inhibit NO release, decrease
the expression of iNOS mRNA (Varga et al. 1999), and promote Bcl-2 and Bcl-xL gene expressions
of rabbit myocytes (Zhang et al., 2005a).
2.3.2 Bamboo Leaves
The active ingredients of the bamboo leaves include abundant flavanoids,
polysaccharides, and trace elements, etc., with antiseptic and anti-oxidant properties (He
and Yue, 2008). The Bamboo Leave Extract may increase coronary flow of the in vitro guinea
pig heart, counteract T wave changes induced by pituitrin, and decrease the myocardial
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infarcted area (Fu et al., 2006). Experiments proved that the bamboo leave flavonoid was
comparable to Egb761 in terms of the content of the flavonoid as well as the capacity of
anti-free radicals (Zhang et al. 2002a). The bamboo leave flavonoid may reduce the occurrence
of myocardial apoptosis, and inhibit the expression of Bax, Cyt-c and caspase-3, but not
of Bcl-2 (Fu et al., 2007b).
2.3.3 Baicalin
Baicalin is a flavonoid compound extracted from Scutellaria baicalensis Georgi.
Baicalin significantly improved the SOD activity of the hypoxic myocytes of neonatal
Sprague-Dawley rats at a concentration of 0.1-10 μg/mL, inhibited MDA production at a 
concentration of 1 μg/mL, and inhibited NO secretion at a concentration of 10 μg/mL (Liu 
et al., 2003a). When baicalin 10-40 mg/kg was given to the rats 5 mins before ligation of
the coronary artery, the post-infarction heart function improved with decreased MDA content
and increased SOD activity (Liu et al., 2003a). Woo et al. (2005) proposed that the
cardioprotective effect of baicalin may not be due to its anti-oxidant effect, because they
observed an adverse rather than a protective effect when baicalin was present during hypoxia.
Pretreatment of neonatal rat cardiomyocytes with baicalin up to 10 μmol reduced LDH delivery 
significantly, while pretreatment with baicalin up to 100 μmol was ineffective. In the rat 
model, baicalin may improve CPK and LDH contents as well as myocardial ultrastructure (Ouyang
et al., 2006). The protective effects of baicalin on heart injury of rats with severe acute
pancreatitis led to better results in the rat mortality, pathological changes of heart,
NF-κB, P-selectin, Bax, Bcl-2, and caspase-3 protein expression levels (Xiping et al., 2007).
2.3.4 Carthamin yellow
More than 60 chemical components have been isolated from the safflower including
flavonoids, lignins, and acetylenics, etc. Carthamin yellow (also named saffloryellow) and
hydroxysaffloryellow A are the main effective components. Carthamin yellow significantly
reduced the LDH and MDA levels, and alleviated free radical damage (Zhang et al., 2003a).
Effective ingredients of Safflower can influence immune system, block platelet-activating
factor receptors, increase NO level and eradicate free radicals. Saffloryellow can inhibit
Na+-K+-ATPase activity and increase cAMP content of the myocardium during
ischemia-reperfusion (Cheng et al., 2000). Piao et al. (2002) found that in the coronary
perfusion experiments in rats intraperitoneal injection of Carthamin yellow 0.8-1.25 g/kg
could remarkably improve the ischemic electrocardiographic changes induced by isoproterenol,
reflecting an antagonistic action on the adrenergic receptors. Mo et al. (1995) found that
Carthamin yellow extract (5-500 mg/mL) blocked calcium influx induced by noradrenaline and
hyperkalemic solution, showing a dose-effect relationship similar to but weaker than that
of verapamil. Safflower injection preserved rat heart displayed improved ultrastructures
compared with the control, with higher SOD activity and lower MDA content (Zhang and Shi,
2003). Carthamus tinctorius extract was associated with a decreased apoptotic index,
decreased expression of Bax, and upregulation of Bcl-2 (Chen and Zheng, 2006).
2.3.5 Erigeron breviscapus (Vant.) Hand-Mazz
Components extracted and differentiated from the Erigeron breviscapus (Vant.)
Hand-Mazz include flavonoids, caffeate, and phenolic acids, etc. Of them, flavonoids had
a strong non-competitive inhibiting effect on protein kinase C, thereby alleviating ischemic
injury (Zhou et al., 2002a). The effective ingredient Erigeron is an inhibitor of protein
kinase C, which participates in ischemic neuron injury, and plays an important role in the
cellular signaling pathways of neuron apoptosis (Lei et al., 2002). Erigeron could promote
myocardial SOD, and decrease myeloperoxidase activities, by which accumulation of free
radicals in the myocardium could be decreased and myocardial injury induced by isoproterenol
was alleviated. Blockage of the calcium channel of the myocytes with a decrease of calcium
influx was observed when Erigeron was used. Erigeron also displayed its effects in promoting
SOD, nitric oxide synthase (NOS) and NO levels in the hypoxic rat model (Mao et al., 2004).
Zhou et al. (2002b) noted Erigeron was useful in regressing left ventricular remodeling
by improving cardiomyocyte hypertrophy, and decreasing collagen volume fraction in
spontaneous hypertensive rats. Erigeron could significantly decrease the number and
percentage of apoptotic nuclei of the myocardium, and upregulate the expression of
apoptosis-inhibiting gene Bcl-2 mRNA (Liu and Chen, 2004). In male Sprague-Dawley rats,
Yuan and Jing Afr J Tradit Complement Altern Med. (2011) 8(2):104-127 109
the myocardial infarct size was significantly reduced by scutellarin (15 and 50 mg/kg),
an active molecule existing in Erigeron breviscapus (Vant.)Hand.Mazz, but not by breviscapine
(5 to 50 mg/kg); and the anti-myocardial infarction effect of scutellarin was dose-dependent.
Compared with the control group, scutellarin (50 mg/kg) remarkably reduced the myocardium
cell apoptosis in myocardial infarction rats (Lin et al., 2007).
2.3.6 Puerarin
Puerarin is an isoflavone extracted and isolated from the dry roots of the legume Pueraria
Lobata (Willd) Ohwi. Puerarin could significantly decrease the CPK delivery of the myocardium.
The heat shock protein 70 expression was much higher in rats receiving Puerarin compared
to those subjected to ischemia-reperfusion (Tang et al., 2007). A significant decrease in
MDA, NO, NOS levels, the leakage of LDH, and a rise in SOD activity occurred in the Puerarin
Group (Yan et al., 2005). Puerarin may also regulate plasma endothelin and NO contents,
hence improving the NO/endothelin ratio (Wang and He, 2004). In the rat hearts pretreated
with 0.24 mmol/L Puerarin for 5 mins, a significant inhibition of Ca2+-induced mitochondrial
swelling was observed (Yang et al. 2008b). In the mitochondria isolated from the rat hearts
pretreated with 0.24 mmol/L Puerarin for 5 mins, a significant inhibition of Ca2+-induced
swelling was observed, and this inhibition was attenuated by 5-hydroxydecanoate (Gao et
al., 2005). Puerarin showed a decrease in apoptosis of the ischemia-reperfusion myocardium
in rats, where the apoptotic cells were significantly reduced during the reperfusion period.
Experimental studies showed that it inhibited cellular apoptosis during myocardial
ischemia-reperfusion injury, increased the expression of Bcl-2, and decreased the expression
of Bax (Yan et al., 2005). Puerarin (120 mg/kg/day, intraperitoneal injection) could increase
serum nitrite concentration in rats with myocardial ischemia, and induce transcriptional
or protein level expressions or activation of endothelial NOS, and the Akt/protein kinase
B phosphorylation (Zhang et al., 2008a).
2.3.7 Total flavonoids of hawthorn leaves
Total flavonoids of hawthorn leaves could alleviate arrhythmias, delay the arrest time,
and decrease LDH delivery and MDA contents, and increase intracellular SOD activity and
NO content of the myocytes of the ischemia-hypoxia model in 3-day Sprague-Dawley neonatal
rats (Ye et al., 2005). Flavonoids of hawthorn leaves (12.5, 25.0, and 50.0 mg/kg) could
alleviate ST segment changes of the rat heart due to ischemia-reperfusion injury (Min et
al., 2007).
2.3.8 Portulaca oleracea L.
Portulaca oleracea L. is the whole plant of purslane of the family Portulacaceae.
Portulaca oleracea L. contains n23 fatty acids, anti-oxidants, amino acids, and trace
elements, which are effective cardiovascular components. Total flavonoids of Portulaca
oleracea L. showed inhibiting actions on pyrogallol autoxidation in a direct dose-effect
relationship (Lu et al., 2004).
2.4. Saponins
2.4.1 Raidix ophiopogonis
Raidix ophiopogonis is a liliaceous plant, and the product currently available
commercially in our country is the radix of Ophiopogon japonicus (Thunb.) Ker-Gawl. Acting
as nourishing yin, and promoting fluid production, it has been found to have multiple
pharmaceutical effects including two-way regulations of blood glucose and immunologic
function, antibiosis, anti-cancer, and in particular cardiovascular effects. Ophiopogon
polysaccharide and Ophiopogonin (60 g raw material/kg, via gastric lavage) could increase
myocardial nutrient flow in a dose-effect relationship (Zhou et al., 2003). Ophiopogcnin
may act on the Na+- and Ca2+-channels to decrease the influx of these ions, and it was effective
reducing the expression of Bcl-2 gene, thereby alleviating calcium overload in the subject
and could be useful to treat the peroxide-induced condition (Zhang et al., 2003b).
2.4.2 Ginsenosides
Radix Ginseng is from Panax Ginseng, a herbaceous plant of the Araliaceae . The chemical
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components include ginsenosides, ginseng polysaccharides, and active peptides, etc.
Ginsenosides can limit myocardial infarction size, regulate metabolism of arachidonic acid,
and increase the 6-Keto-PGFlα/TXB2 ratio (Li et al., 2006). The optimal concentration of
ginsenosides for myocardial protection was 20-80 mg/L, however, this drug may show a harmful
effect on the myocardium when the concentration was 160 mg/L (Chen et al., 1994). Yuan et
al. (1997) obtained a similar result in a cardiac concordant xenotransplantation rat model
where the proper concentration of the drug was 40 mg/L; whereas the protective effect
diminished and it may jeopardize the myocardium when the concentration was 320 mg/L. They
demonstrated that the Rb component may predominate at a lower concentration, while the harmful
component may function instead at a higher concentration. Zhang et al. (1998) found that
ginsenosides Rb1, Rb2 and Rb3 worked as both anti-oxidant and calcium channel blockage by
protecting myocytes from apoptosis during ischemia-reperfusion. Both Rb1 and Re
significantly stimulated the NOS activity in a concentration-dependent manner. It
demonstrated a direct depressant action of ginsenosides on cardiomyocyte contraction, which
may be mediated in part through the increased NO production (Scott et al., 2001). The typical
apoptotic features in the rat myocardium with ischemia-reperfusion injury could be improved
with the use of ginsenosides while the intracellular expression of Bcl-2 gene was
significantly increased (Zhou and Xu, 2001). In the rat ischemia-reperfusion injury model,
ginsenoside Rb, lavage for consecutive 7 days may reduce serum enzymatic activities and
MDA content, while increasing, SOD and GSH-Px activities, and justifying the PGI2/TXA2 ratio
(Qu et al., 2007).
2.4.3 Panax quinquefolium L.
Panax quinquefolium L. is a perennial persistent root herb of the Araliaceae. Its
bioactive materials are saponins, polysaccharides, flavonoids, essential oils and trace
elements, etc. Panax quinquefolium total saponins (30, 100, and 300 μg/mL) could decrease 
the delivery of aspartate aminotransferase, CPK and LDH in the isolated rat heart Langendorff
model (Cao et al., 2003). Intraduodenal administration of ginsenosides from the leaves and
stems of Panax quinquefolium to the myocardial ischemic models of dog and rabbit led to
a reduced infarction area, reduced serum levels of free fatty acid and MDA, decreased LDH,
CPK and aspartate aminotransferase, and an increased SOD activity (Ding et al., 2002). At
a concentration of 1.5 mg/mL, it may inhibit the increase of the intracellular calcium
comparable to the effect of verapamil (0.5 μmol/L) (Guan et al., 2004). Panax quinquefolium
total saponins could decrease the left ventricular load, and decrease myocardial oxygen
consumption, and increase the blood supply to the ischemic myocardium (Liu et al., 2001).
Panax quinquefolium buffered significantly the changes in the ventricular weight and cardiac
coefficient of the ventricular remodeling rats, and improved the arterial pressure, and
the left ventricular end diastolic pressures. Panax quinquefolium also inhibited the
thickening of the cardiac muscle fibers and improved myocardial interstitial edema, showing
same effects as angiotensin converting enzyme inhibitor benazepril (Ju et al. 2007). Panax
quinquefolium could significantly improve the endothelial function and prevent from
ventricular remodeling post-myocardial infarction, regulate the lipid metabolism and
increase the PGI2/TXA2 ratio (Fan et al., 2009). Improved expressions of vascular endothelial
growth factor and basic fibroblast growth factor in the infarcted myocytes, with increasing
vasogenesis in the ischemic region have been shown in the panax quinquefolius saponin-treated
rats (Wang et al., 2007a). The use of panax quinquefolium correlated with a significant
reduction in apoptosis in rats after acute myocardial infarction, and a downregulation of
Fas and an upregulation of Bcl-2 protein expressions in rats (Yin et al., 2005).
2.4.4 Notoginseng Saponins
Notoginseng is the radix of Ranax Notoginseng (Burk) F. H. Chen, a perennial herbaceous
plant. The main active component of Notoginseng is Panax notoginseng saponins. Li et al.
(1990) found that Panax notoginseng saponins reduced the infarct area, and decreased CPK
release of the myocardium of rats with coronary artery ligation and recannalization. Panax
Notoginseng saponins could improve the Ca2+ pump activity on the membranes of myocardial
sarcoplasmic reticulum, reduce myocardial intracellular Ca2+, and inhibit left ventricular
remodeling (Deng, 2007). Pretreatment with Panax notoginseng saponins significantly
protected the mice from doxorubicin-induced cardiotoxicity as evidenced from improved
ventricular contractile function, lower levels of serum LDH, CPK and CK-MB, minimal
morphological changes in the hearts, and normalization of myocardial SOD, GSH-Px and catalase
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activities (Liu et al., 2008). Notoginseng saponins significantly improved myocardial NO
level and constitutive NOS activity, lowered collagen content and iNOS activity, and
inhibited cardiac hypertrophy in the myocardial hypertrophy rat model induced by
isoproterenol (Zhou et al., 2006). Inhibited tumor necrosis factor (TNF)-α delivery, NF-κB
activation and neutrophil infiltration and decreased ICAM-1 expression were seen with
Notoginseng saponins pretreatment (Gu et al., 2005; Tang et al., 2003). Notoginseng saponins
had an apparent inhibitory effect on cellular apoptosis induced by angiotensin II.
Notoginseng saponins (50 mg/L) showed a remarkably decreased myocardial apoptotic rate and
a more alleviated calcium overload comparing to Angiotensin II Group (Chen et al., 2005).
The Notoginseng saponins-administered endothelial cells showed a much lower apoptotic rate,
with downregulation of Fas expression and upregulation of Bcl-2 (Lǚ and Liang, 2005). 
2.4.5 Gross saponins from Tribulus terrestris
Gross saponins from Tribulus terrestris could decrease the apoptotic rate at any dose,
but a large dose may upregulate, while a small dose may downregulate Bcl-2 expression. Besides,
it may significantly decrease the TNF-α and interleukin (IL)-1β contents with obvious NF-κB
p65 nucleus translocation at any dose in a Sprague-Dawley neonatal rat model of myocardial
ischemia-reperfusion injury (Yin et al., 2006). It may also promote δPKC and εPKC expressions 
in neonatal rat model of hypoxia (Sun et al., 2008).
2.4.6 Sasanquasaponin (SQS)
Sasanquasaponin is a mixed saponin extracted from the dregs after oil extract of the
seeds of the Theaceae plant Camellia oleifera Abel. Sasanquasaponin has shown its
anti-Na+-Ca2+ overload effect by decreasing Mg2+, and increasing Na+ and Ca2+ contents, and
decreasing the Na+-K+-ATPase and Ca2+-Mg2+-ATPase activities of the mitochondria of rat
myocardial ischemia model (Li et al., 2007b). It reduced LDH release and increased the cell
viability in a dose-dependent manner up to 10 μmol and concomitantly decreased MDA and 
oxidized glutathione contents, while significantly increased the activities of SOD (Chen
et al., 2007). By using an NO delivery antagonist, the pretreating effect of Sasanquasaponin
was weakened or abolished, suggesting that this agent may work at least partly by activating
NOS and inducing the formation of NO and adenosine (Huang et al., 2001).
2.4.7 Gypenosides
Gypenosides are saponins derived from Herba Gynostemmatis, the dry whole plant of
Gynostemma pentaphyllum (Thunb.) Mak. of Cucurbitaceae family. Experiments revealed that
Gypenosides may reduce myocardial MDA content, and inhibit the delivery of serum CPK and
plasma endothelin in the rat model of myocardial ischemia-reperfusion injury, and remarkably
increase myocardial SOD and plasma NO levels, balancing the NO/endothelin ratio (Zheng et
al., 2002). The cardioprotective effect of Gypenosides may also depend on calcium overload
amelioration and abnormal excitement inhibition (Qi and Zhang, 2003). Moreover, Gypenosides
inhibited c-fos gene expression in a dose-dependent manner with decreasing concentrations,
while it showed no influence on sis gene expression (Qi and Zhang, 2003). Tanner et al.
(1999) found that the extract of Gynostemma pentaphyllum at 0.1-100 µg/mL elicited
concentration-dependent vasorelaxation of porcine coronary rings that was antagonized by
the NOS inhibitor N(G)-nitro-l-arginine methyl ester. Indomethacin had no significant effect
on Gynostemma pentaphyllum-induced relaxation. The results demonstrated that the extracts
of Gynostemma pentaphyllum directly stimulated NO release, but not the prostanoid production.
The expression of TNF-α was significantly increased in the Ischemia-Reperfusion Group (Zheng
and Zheng, 2007). Compared with the Hypoxia-Reoxygenation Groups, the positive expression
index of Fas/FasL proteins were significantly lower in groups with different doses of total
flavones of Gynostemma pentaphyllum (Thunb) Mak., suggesting that the total flavonoids could
protect the myocardium against hypoxia-reoxygenation injury by decreasing the production
of TNF-α, downregulating the protein expression of Fas/FasL genes, and inhibiting myocyte
apoptosis (Li et al., 2007c).
2.4.8 Dioscin
Dioscin exists extensively in Dioscoreaceae, Liliaceae, and the legume plants. It can
be used for the purposes of eliminating phlegm, desensitization, anti-inflammation,
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anti-tumor, protection against myocardial ischemia, decreasing blood viscosity, reducing
platelet aggregation, and decreasing triacylglycerol, etc. (Zhao et al., 2008). Dioscin
could alleviate calcium overload of the experimentally hypoxic myocytes (Liu et al., 2004a).
In the rat models of myocardial ischemia-reperfusion injury, either a high dose dioscin
(300 mL/kg/day) or a low dose dioscin (150 mL/kg/day) may lead to a smaller myocardial
infarction size and better cardiac function comparing to the control (Zhao et al., 2008).
The in vitro Sprague-Dawley neonatal rat model of myocyte hypoxia showed decreased LDH (4.534
± 0.872 U/L), cardiac troponin I (0.682 ± 0.091 μg/mL) levels and a decreased intracellular 
free calcium concentration (479.99 ± 57.94 nmol/L) when treated with dioscin. Experiments
also revealed that dioscin alleviated the calcium overload of the hypoxic myocytes by
enhancing the expression of calcium pump SERCA2 on the sarcoplasmic reticulum (Liu et al.,
2004b). High dose of dioscin (100 mL/L) resulted in a higher SOD activity, and lower MDA
and NO contents comparing to the normal control and the hypoxia/reoxygenation groups (Ni
et al., 2007).
2.4.9 Total saponins of Semen Ziziphi spinosae
Total saponins of Semen Ziziphi spinosae are a kind of effective components extracted
from Chinese medicine obtained from the seed of Ziziphus spinosa Hu. These agents had shown
blood pressure lowering, anti-arrhythmic and anti-ischemic effects. In the
anoxia-reoxygenation model of cultured neonatal rat myocytes, total saponins of Semen Ziziphi
spinosae could markedly and dose-dependently decrease MDA content, elevate SOD activity
and increase membrane fluidity, proving an effect of anti-peroxidation induced by
anoxia-reoxygenation (Wan et al., 1995). In cultured neonatal rat myocytes, the increase
of LDH release from the damaged myocardial cells induced by oxygen-glucose deprivation,
ehlorpromazine or mitomycin C could be attenuated by Ziziphi spinosae (33 μg/mL) (Chen et
al., 1990). Compared with the control, the experimental group treated with Semen Ziziphi
spinosae showed significantly smaller myocardial infarct area, and significantly decreased
ST segment and T wave on electrocardiogram (Zhang et al., 2005b).
2.4.10 Paeoniflorin
Paeoniflorin is extractable from the radix of Paeonia albifolra Pall. Paeoniflorin
can inhibit platelet aggregation, dilate coronary arteries, increase coronary flow, and
protect acute myocardial ischemia. However, the exact cardiovascular mechanisms of
Paeoniflorin remain unclear. Paeoniflorin showed an interdiction to L-type calcium channels
in the isolated rat myocytes for patch clamp research, but lack of frequency-dependent
inhibition (Zhang et al., 2003c). High-dose of Paeoniflorin remarkably decreased the hazard
index, lowered myocardial CPK and LDH, and reduced the apoptotic index (Zhang et al., 2008b).
Both paeoniflorin and paeonol, two main active compounds of the Paeonia albiflora Pallas,
were shown to lead to a reduced myocardial infarct size in rats through protection from
apoptosis (Nizamutdinova et al., 2008).
2.4.11 Hyperin
Hyperin is a common component of many Chinese herbal drugs. Hyperin (12.5, 25 mg/kg/day
× 3, intraperitoneal injection) decreased rat myocardial infarct area, inhibited serum CPK
and LDH elevation, and promoted myocardial SOD content (Li et al., 2001a). Hyperin (25,
50 mg/kg) had obvious protective effect on rat myocardial apoptosis 3.5 hrs after reperfusion,
and Hyperin (0.5-50.0 μmol/L) may reduce the apoptosis formation in rat myocytes with 
hypoxia-reoxygenation (Li et al., 2002a), and inhibit dose-dependently LDH delivery and
calcium overload in the myocytes (Li et al., 2001a). Hyperin at 12.5 μg/mL, 50 or 12.5 μg/mL, 
and 50 μg/mL, 50 or 12.5 μg/mL was found to have a protective effect on myocardial injury 
caused by adriamycin, by mitomycin, by oxygen-glucose deprivation or by
hypoxia-reoxygenation (Xu et al., 2000).
2.4.12 Acanthopanax Senticosus Saponins or Acanthopanax senticosides
Radix Acanthopanacis Senticosi is an Araliaceae plant, with a botanical name of
Eleutherococcus senticosus (Ruper.et Maxim.) Maxim., containing eleutherosides A~G, I, K,
L, and M. Acanthopanacis Senticosi could improve T wave elevation and decrease of heart
rate in the rabbit myocardial ischemia model subjected to pituitrin injection, and promote
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regeneration of the surface cells. In such a model, rat myocardial ischemia was significantly
improved with a preserved SOD activity and a reduced MDA production. Acanthopanacis Senticosi
could markedly increase calmodulin content, suggesting that a nucleic acid system pathway
might be followed by Acanthopanacis Senticosi in improving heart function (Wang and Juan,
2005). Treatment with Acanthopanax senticosus significantly improved the survival rate of
mice. Acanthopanax senticosus pretreatment inhibited the elevation of TNF-α, and decreased
the iNOS level in serum and liver, and inhibited the NO overproduction (Lin et al., 2008).
Total saponins from the leaves of Acanthopanax Senticosus could weaken the contractility
of isolated Wistar rat heart in a significant dose-dependent manner, in accordance with
what was noted in a weakened excitation-contraction coupling. Acanthopanax senticosides
Sb (50-200 mg/L) was found to decrease action potential of cultured Wistar rat myocytes,
which could be reversed by Ca2+ 80 mg/L, showing a similar calcium channel blocking effect
to nimodipine (Zhan et al., 1995).
2.5. Coumarin
2.5.1 Andrographis paniculata
Andrographis paniculata is the dry aerial part of the Acanthaceae plant Androp raphis
paniculata (Buri. f.) Nees. Present studies on Andrographis paniculata concentrate on
Andrographolide and the flavonoid component API0134. This flavonoid component API0134 could
improve canine heart function, decrease the extent of myocardial infarct area, alleviate
the extent of myocardial injury, and decrease the occurrence of arrhythmias. Meanwhile,
it could promote the production of prostaglandin, raise the PGI2/TXA2 ratio, and inhibit
the granulocyte from producing free radicals. API0134 had an extensive scavenging function
on H2O2, O
2-, and ·OH, and inhibited the induced aggregation of human-washed platelets.
Prophylactic API0134 for 4 and 8 weeks significantly raised NO and cGMP contents and SOD
activity, and decreased endothelin and lipid hydroperoxide contents (Zhang et al., 2002b),
and maintained the NO/endothelin balance (Wang et al., 2003). API0134 (50 mg/kg, i.v.) in
rabbits may raise the cAMP level, slightly increase cGMP, alleviate degranulation and
decrease cytoplasmic calcium concentration (Wu et al., 2002). Alleviation of calcium overload
by API0134 may also be contributable to the effect of promoting Na+-K+-ATPase and Ca2+-ATPase
activities on the cellular membrane of the myocardium. The cardioprotective effect of
andrographolide was in a time-dependent manner with upregulation of glutathione (Woo et
al., 2008). Andrographolide may dose-dependently upregulate ICAM-1 expression induced by
TNF-α, and inhibit apoptosis. Andrographolide could inhibit cytochrome C from entering into
the cytoplasm and eliminate mitochondrial potential energy, thereby preventing from
activation of caspase-3 and -9, and inhibiting the mitochondrial pathway of apoptosis.
Andrographolide may induce the activation of an anti-apoptotic signaling protein kinase
Akt and phosphorylation of the pro-apoptotic molecule BAD (Liu et al., 2003b).
2.5.2 Praeruptorin C
Praeruptorin C is an effective component extracted from Peucedanum praeruptorum Dunn.,
with effects of vascular dilation, myocardial contractile inhibition, and myocardial
compliance improvement. Praeruptorin C could inhibit myocardial LDH delivery, increase
intracellular SOD concentration in the neonatal rat model of myocyte damage (Zheng et al.,
2007). Intraperitoneal injection of praeruptorin C could alleviate myocardial
ischemia-reperfusion injury, promote coronary flow recovery, prevent the decrease of left
ventricular systolic pressure and the dp/dt max, and inhibit CPK delivery, with similar
effects to nifedipine (Yang et al., 1992). The Na+-Ca2+ exchanger mRNA level was much lower
in neonatal rat myocytes with praeruptorin C pretreatment than that of the
Ischemia-Reperfusion Group (Xi et al., 2008). Praeruptorin C showed predominant
pharmacological actions of lowering blood pressure and dilating the coronary arteries with
a possible mechanism of calcium antagonism (Kong et al., 2002). Comparing with the
Hypoxia-Reoxygenation Group, the LDH value, intracellular calcium fluorescence intensity
level, and cellular apoptotic index were remarkably decreased (Chen and Zhu, 2007).
3. Lignanoids
Fructus schisandrae chinensis
The effective components of Fructus schisandrae chinensis are lignanoids, essential
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oils, organic acids, and polysaccharides, etc., with lignanoids being the most important
one, contained 19.2% in the fruits. Schisandra chinensis baill extractum had a strong
protective effect on hypoxic or ischemic injury in animals. It significantly extended the
survival time of the animals in the condition of constant pressure and hypoxia, and
significantly improved the T wave changes on electrocardiogram induced by pituitrin (Lin
et al., 1998). The protective effects of this agent were experimentally observed as to
increase SOD activity of erythrocyte, markedly lowered the lipid hydroperoxide content of
the venous blood, and lessen the myocardial infarct extent (Guo et al., 2006).
4. Essential oils
4.1 Radix angelica sinensis
Radix angelica sinensis is the dry root of Angelica Sinensis (Oliv.) Diels, a spignel
plant. Radix angelica sinensis has antagonistic effects on oxidized low density lipoprotein
thereby leading to a reduced NO secretion of the endothelial cells and an increased ICAM-1
expression. The possible mechanism may be associated with the cholinergic receptor. Radix
Angelica sinensis injection was proved to have a myocardial protective effect by way of
calcium influx blockage similar to that of verapamil. Radix Angelica sinensis extract may
improve anti-oxidant capacity, activate ERK signaling transduction pathway, and enhance
the expression of endothelial NOS. Radix angelica sinensis could upregulate the expression
of Bcl-2 and downregulate the expression of Bax, causing a decreased Bax/Bcl-2 ratio, so
that apoptosis of the myocytes could be inhibited, and left ventricular function and
ventricular remodeling improved (Shangguan et al., 2008). Radix angelica sinensis injection
could effectively inhibit myocardial hypertrophy induced by angiotensin II (Yu et al., 2006).
In the Radix angelica sinensis injection treated rats, the expression of P57kip2 protein
was strong (Feng et al., 2008b), whereas the expression of cyclin-dependent kinase-2 protein
in the myocytes was weak, suggesting that Radix angelica sinensis may have an impact of
positive cell-cycle regulating agent (Feng et al., 2008a).
4.2 Rhizoma Chuanxiong
Rhizoma Chuanxiong is the dry rhizome of Ligusticum Chuanxiong Hort, a spignel plant.
Chuanxiong-pathalide A can increase coronary flow and myocardial contractility, and can
significantly improve the delivery of LDH, MDA and SOD in an isolated rat heart model of
ischemia-reperfusion injury. Increased NO and NOS activities were observed in culture
solution of the Chuanxiong-pathalide A Group, associated with a reduced endothelin activity,
an increased iNOS mRNA, and a decreased endothelin mRNA expression (Gao et al., 2007).
Ligustrazine, with a chemical name of tetramethylpyrazie (TMP), is the key component of
Chinese herb Rhizoma Chuanxiong. Ligustrazine obviously alleviated the degeneration and
necrosis, and reduced the infiltration of inflammatory cells of the ischemic myocardium
of rat ischemia-reperfusion model (Li et al., 2004). The mechanisms were surmised to be
the inhibition of the mitochondrial calcium overload, and the decrease of the mitochondrial
NOS activity. Ligustrazine injection, containing 25 mg/mL of the drug, promoted the syntheses
of proteins and RNA of the myocardium with oxygen-glucose deprivation, and enhanced the
expression of constitutive NOS mRNA (Tan et al., 2006). To strengthen the expression of
NOS gene was hence regarded as the main strategy of the prevention and treatment of
oxygen-glucose deprivation. Moreover, ischemia-reperfusion may induce myocyte apoptosis
and upregulate c-fos gene expression of the myocardium (Li et al., 2000), hence Ligustrazine
might have played a protective role by attenuating c-fos gene expression and apoptosis (Yi
et al., 1995).
5. Alkaloids
5.1 Leonurus japonicus Houtt
Leonurus japonicus Houtt was found to have a good effect on myocardial
ischemia-reperfusion injury by protecting anti-oxidation system. relieving lipid
peroxidation, protecting myocardial ATPase, and alleviating calcium overload (Zhao et al.,
2004). In experimental rats, Leonurus Japonicus injection 0.8 mg/100 g body weight was given
intravenously immediately after the ligation of the left anterior descending coronary artery,
resulted in an elevated SOD activity, reduced MDA, LDH and CPK contents, decreased arrhythmic
rates and better morphological changes of the myocardium (Shang et al., 2007).
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5.2 Tetrandrine
Tetrandrine mainly exists in the root of Stephania tetrandra S. Moore, a perennial
woody liana. Tetrandrine has calcium antagonism and strong non-specific anti-inflammatory
effects, and can effectively prevent the inflammatory reaction during myocardial
ischemia-reperfusion. Deng et al. (1993) found that tetrandrine predominently inhibited
the isolated rat heart from delivering LDH and proteins from the myocardium with calcium
overload, reduced myocardial infarct size and led to declined inflammatory parameters, such
as IL-1, TNF-α, platelet-activating factor, and myeloperoxidase, etc. Guan et al. (1998)
obtained similar results in canine models. They observed that the myocardial infarct size
was much smaller and IL-6, TNF-α, and myeloperoxidase levels were much lower in the
Tetrandrine Group than the control. At 32 μmol/L, it showed negative inotropic action on 
the isolated cat papillary muscle, inhibiting the contractility induced by adrenalin, and
the increase of ±dp/dt max (Jiang et al., 2002). The negative inotropic action was frequency-
and voltage-dependent, and could be reversed by external calcium supplement. Tetrandrine
could decrease the activity of the Ca2+-ATPase of the endoplasmic reticulum, compatable to
nifedipine. Tetrandrine pretreatment could reduce the production of TNF-α and inhibit the
activation of NF-κB during myocardial ischemia (Wang et al., 2007b). In the Tetrandrine
Group, the LDH activity and MDA content was decreased and SOD activity increased (Chen et
al., 1998). Tetrandrine pretreatment remarkably lessened myocardial ischemia-reperfusion
injury. Comparing with sham, tetrandrine had much less apoptotic myocytes, and a much smaller
apoptotic index (Chang et al., 2006a). Zhang et al. (2003d) found a much lower apoptotic
rate (mean 3.2%) in the Tetrandrine Group of Sprague-Dawley neonatal rat model of myocardial
ischemia-reperfusion.
5.3 Berberine
Berberine is an isoquinoline alkaloid found in such plants as Berberis, goldenseal
(Hydrastis canadensis), and Coptis chinensis. Berberine could decrease calcium influx,
stabilize the cellular membrane, and prevent cell necrosis. Berberine had positive inotropic
action and improved heart function of heart failure patients (Cui, 2006). In mice Langendorff
heart perfusion model, berberine 0.5 mmol/L added into modified Euro-Collins solution led
to a better left ventricular peak systolic pressure and dp/dt max results and less myocardial
water content comparing to the control (Luo et al., 2000). The administration of berberin
(5, 10 and 20 mg/kg, respectively) and positive control drug Captopril (45 mg/kg) for
consecutive 10 weeks had relieving effects on hydroxyproline content and interstitial
collagen volume fraction in the rat model with hypertrophic cardiomyopathy induced by
pressure-overload, indicating that berberin may relieve the ventricular remodeling through
inhibiting the fibrosis of myocardial interstitium (Hong et al., 2006).
6. Amino acids, peptides, proteins and enzymes
6.1. Cordyceps sinensis
Cordyceps sinensis is abbreviated as worm grass. It is a complex incorporating a stroma
of fungi from paecilomyces and the cadaver of its host Hepialidae Hepialus armoricanus.
Natural Cordyceps sinensis contains 25% protein, 8.4% fat, 18.5% fibre, 29% carbohydrate
and 4.1% aldosterone-stimulating hormone. Besides these compounds there are uridine,
2,4-dichloropyrimidine, adenine, adenosine, mannitol, ergosterol and stearic acid, etc.
Cordyceps sinensis contains a lot of polysaccharides, accounting for 3%-8% of the total
dry weight. In the cultured Cordyceps sinensis, polysaccharides are secreted from the
mycelium. Chiou et al. (2000) discovered that Cordyceps sinensis-induced vasorelaxation
was mediated by the endothelium possibly by stimulating the release of NO and
endothelium-derived hyperpolarizing factor in a dose-dependent manner. Cordyceps sinensis
extracts could promote NOS activity, and produce biological effects like NO production and
coronary artery dilation, except for that they may decrease myocardial infarct size, inhibit
serum CK-MB and LDH elevation, improve SOD activity and decrease MDA content (Liu et al.,
1999). Liu et al. (1999) tested 20% solution of the ethanol extracts of Cordyceps sinensis
at a concentration of 0.2 mL drug solution in one litre of Krebs-Henseleit-Bicarbonate
solution in the Langendorff rat heart model, and found that the extracts improved myocardial
metabolism and attenuated myocardial damage by decreasing myocardial MDA contents and
preserving myocardial ATP, ADP and AMP. Yamaguchi et al. (2000) found that the water extracts
of the fruiting bodies of cultured Cordyceps sinensis significantly suppressed the increased
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serum lipid peroxide level but not other lipid levels in a dose-dependent manner in the
atherosclerotic mice. Such preparations could decrease the calcium concentration of the
normal myocytes as well, and therefore alleviate calcium overload of the
hypoxia-reoxygenation myocytes (Yu et al., 1998).
7. Other
7.1. Allicin
Allicin is a kind of anti-bacterial substance in the squamous bulb of Allium sativum
L. Allicin could improve the left ventricular dp/dt max, left ventricular systolic pressure,
left ventricular end diastolic pressure and endothelin values of the rabbit with acute
ischemia-reperfusion injury (Liao et al., 2001). Allicin could promote SOD and GSH-Px
activities, reduce plasma endothelin level, balance endothelin and NO, and thus improving
vascular endothelial function (Li et al., 2001b; Li et al., 2002b). Allicin was more resistant
to apoptosis of cultured hypoxia/reoxygenation myocytes of the neonatal rat (Shi et al.,
2006).
Discussion
Chinese herbal medicine consists of complex chemical components, showing relationships
with their bioactivities. Active ingredients were defined as ingredients of herbal medicines
with therapeutic activity, where one or more chemical agents from a single or compound drugs
should be over 50% (80%, if in a form of injection) of the total extracts (Sun, 2004). The
main effective components include carbohydrates, glycosides, lignanoids, alkaloids, amino
acids, peptides, proteins and enzymes. Clinical observations in patients with coronary heart
disease and angina pectoris showed cardioprotective effects of preparations of some Chinese
herbal drugs, such as Radix puerariae, Ginkgo biloba L., Radix salivae miltiorrhizae,
Astragalus membranaceus Bge, Radix acanthopanacis semticosi, Chuanxiong rhizome, Allii
sativi, and Notopterygium incisium, etc. (Hu and Yan, 2002). Besides, myocardial
ischemia-reperfusion experiments were made in animals by coronary artery occlusion (ligation,
balloon compression, or thromboembolism), drug induction (pituitrin- or ergometrine-induced
coronary arterial spasm, or isopreterenol increased myocardial oxygen uptake), or in vitro
(the Langendorff reperfusion model, or isolated heart, myocardial slices or cultutured
myocytes subjected to ischemia) (Ni, 2004). The exact mechanisms of the therapeutic effects
of Chinese medicine remain unclear (Ho and Jie, 2007). However, modern studies revealed
that the possible cardioprotective mechanisms of the herbal agents were multifactorial,
including improving hemodynamic haemorrheology, modulating vasoactive substance and calcium
balance, protecting chondrosome, inhibiting apoptosis, clearing free radicals, and
promoting vasogenesis (Zhang et al., 2007).
A polysaccharide is class of relatively complex, high-molecular weight carbohydrates
consisting of long-chains of serial monosaccharides joined together by the glycosidic bonds.
It exists extensively in the cellular membrane of animals and the cellular wall of the plants
and microorganisms. Polysaccharides of Chinese medicine have been noted to have a lot of
pharmaceutical effects such as immune modulations, anti-inflamation, anti-virus, anti-tumor
and anti-aging, etc., with the anti-oxidative effect being the basis of the above properties.
Nowadays, polysaccharides from more than a hundred Chinese herbal drugs including Lycium
chinensis, Coriolus versicolor, Ganoderma lucidum, garlic, Radix astragali, Cordyceps
sinensis, gingko, and notoginseng, etc., have been proved to have an anti-oxidant effect
(Xin and Liu, 2000).
The cardiovascular effects of cardiac glycoside containing medicinal herbs were
detected by traditional Chinese physicians at the beginning of the first century, and were
proved to have potential inotropic and electrophysiological actions (Lu, 1987). Salvia
miltiorrhiza, Panax notoginseng, hawthorn and Polygonum multiflorum Thunb are four medicinal
herbs commonly used in traditional Chinese medicine and have previously been shown to provide
cardiovascular protection and to be physiologically active on human vascular endothelial
cells. The actions of Polygonum multiflorum Thunb and hawthorn to reduce apoptosis, and
of Salvia miltiorrhiza and Panax notoginseng to inhibit the adhesion molecule expression
may help protect the endothelial function and inhibit atherogenesis (Ling et al., 2008).
Radix Salviae miltiorrhizae is officially listed in the Chinese Pharmacopoeia used for angina
pectoris, and has been tested in clinical trials of ischemic diseases such as angina, heart
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attack and stroke (Xu et al., 2007). Experiments on myocardial ischemia-reperfusion injury
in the isolated rat hearts illustrated the cardioprotective effects of purified Salvia
miltiorrhiza extract perfused at a constant flow of 7-9 mL/min via the aorta (Chang et al.,
2006b). Therapeutic treatment with salvianolic acids significantly reduced
doxorubicin-induced toxicity, including elevation of body weight and the heart weight/tibia
length ratio, decrease of CPK, improvement of electrocardiogram and myocyte vacuolation
(Jiang et al., 2008).
Saponins are an important class of natural products with bioactivity. Saponins are
composed of dioscingenin, glucose, uronic acid, and other organic acids. In the saponin
molecule, there are many hydroxide radicals with large polarity. Furthermore, saponins
usually share common physicochemical properties and similar bioactivities, such as an
anti-platelet aggregation effect. Recent studies showed that saponins commonly have
significant anti-oxidant effect, playing an important role in protection against many
pathophysiological phenomena including senility, atherosclerosis, and ischemia-reperfusion
injury (Xu et al., 2004). The cardioprotective effect of saponins rest on protection from
myocardial damage caused by chemical or physical injury. For example, astragaloside can
protect cultured neonatal rat myocytes from damage caused by free radicals and mitomycin
C, whereas gypenosides can protect the contractility of the endotoxin-shocked guinea pig
papillary muscle and rat myocardium. Sasanguasaponin can improve myocardial contractility,
decrease the production of CPK and myocardial calcium content, and enhance cellular
Na+-K+-ATPase and mitochondrial Ca+-ATPase activities (Fan and Liao, 2003).
Flavonoids regulate cardiovascular function by way of their general characters of
anti-oxidation and inflammatory inhibition. As bioflavonoids commonly contain active
phenolic hydroxy group, they have good anti-oxidant property. Flavonoids can inhibit the
oxidative modification of low density lipoprotein induced by Fe2+ and Cu2+, and reduce the
production of oxidized low density lipoprotein. They can also increase myocardial SOD and
GSH-Px activities, decrease the capillary brittleness and permeability, and improve the
microcirculation and rheology. Flavonoids may have an inhibitory effect on the expression
of the adhering receptors. Its anti-inflammatory property may be associated with the
inhibition of lipoxygenase during the biosynthesis of prostaglandin (Lan et al. 2005).
Alkaloids are widely distributed in the plant kingdom, in the families of Dicotyledoneae,
such as Ranunculaceae, Menispermaceae, Papaveraceae, Solanaceae, Apocynaceae, and Rutaceae,
etc., and Monocotyledoneae and lower plants as well. Alkaloids are always strongly active,
being major active ingredients of Chinese herbal medicine (Feng and Shang, 2009).
The main pharmaceutical applications of polysaccharides are improvement of immunity,
those of phenolic compounds are anti-senility while those of alkaloids are anti-tumor,
inhibition of cardiovascular and digestive systems, and as an analgesic and an antipyretic.
Left ventricular function improvement, isotropic effect, and free radical scavenging and
anti-oxidant activities have been thought to be what the alkaloids contribute to myocardial
preservation (Feng and Shang, 2009). Alkaloids may also inhibit platelet aggregation of
the rabbit, decrease the myocardial contractility of the rabbit and guinea pig, reduce blood
pressure and inhibit respiration. Some alkaloids showed a muscarinic effect and a nicotinic
excitation (Yan et al., 2000).
Chinese medicinal monomers, such as Ligustrazine (Zhou, 2000), Radix angelica sinensis
(Zhou, 2000), Puerarin (Deng et al., 2005), and Allicin (Li et al., 2001b), etc., may realize
their cardioprotective effects by increasing plasma endothelin level, and decreasing the
NO production. However, some monomers may show two-way regulations on the NO production
according to their impact positions, dosage, concentration, and duration of action. For
instance, Ligustrazine may induce the expression of NOS mRNA in oxygen-glucose deprivation
myocytes, and increase NO production; meanwhile Ligustrazine can inhibit the expression
of NOS and its genes and decrease NO production and therefore inhibit the formation of
pulmonary hypertension and pulmonary vessel remodeling (Xu et al., 2001).
Calcium overload and free radicals are the main factors responsible for
ischemia-reperfusion injury (Bagchi et al., 1997). Panax notoginseng saponins can improve
the calcium pump activity of the sarcoplasmic reticulum membrane of the myocardium, and
decrease the intracellular calcium. Allicin, liquorice, Rhizoma chuanxiong, and Radix
acanthopanacis senticosi can function as calcium influx antagonists. The anti-oxidant
property of Chinese herbal medicine display activities such as inhibiting the production
of free radicals during ischemia-reperfusion, inhibiting lipid peroxidation induced by free
radicals, protecting myocardial SOD activity, and counteracting damage by exogenous free
radicals.
The ability to decrease myocyte apoptosis, and to effectively block the pathways of
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myocyte apoptosis have become valuable cardioprotective methods of Chinese medicine.
Astragalus can inhibit myocyte apoptosis of rabbit during ischemia-reperfusion period, and
so could puerarin when it was used as suplement in cardioplegia. The mechanism of Egb761
to inhibit myocardial apoptosis may be probably associated with Ginkgolide B, which may
promote endogenous anti-oxidant activity, prevent cellular membrane from damage from active
oxygen, and alleviate calcium overload by counteracting platelet-activating factor and
inhibiting lipid peroxidation caused by free radicals (Yu et al., 2001). Moreover, TNF-α 
may play an important part during the activation of the neutrophilic granulocytes. By this
way, vascualr dysfunction and myocardial damage develop. Despite the appearance of many
cytokines after myocardial ischemia, elevation of the TNF-α expression can only be apparent
during reperfusion (Hansson, 1993; Herskowitz et al., 1995). In addition, IL-6 and -1 may
impact on the myocytes and vascular endothelial cells, inducing the production of ICAM and
prompting the adherence of the neutrophils and further ischemia-reperfusion injury. Puerarin
can inhibit the increase of IL-6 secretion and oversecretion of IL-6 by hypoxic myocardium
(Zhu et al. 2001).
In cardiac surgery, intermittent infusion of cold cardioplegia remains the main
cardioprotective method, by which the myocardial metabolic rate can be decreased and
myocardial endurance to hypoxia increased. Clinical study illustrated that the crystalloid
cardioplegic solution containing puerarine (2 mg/kg) led to much less lactate and MDA contents,
CPK and CK-MB delivery, and much better myocardial ultrastructure in comparison to the control
in cardiac surgical patients (Yue and Hu, 1996). Cardioplegic infusion with ginsenosides
(80 mg/L) or panaxadiol saponins (40 mg/L) as a supplement in rat heterotopic cardiac
abdominal transplantation model obtained a higher myocardial GSH-Px activity, and lower
lipid hydroperoxide content and mitochondrial score relative to the control (Yuan et al.,
2003). Liu et al. (1998) reported St. Thomas II cold cardioplegia containing ginsenosides
80 mg/L was used in a transplanted rat heart after global ischemia for 60 mins and reperfusion
for 30 mins. The SOD activity in the myocardium treated with ginsenosides was significantly
higher, whereas the MDA and oxygen free radicals in the myocardium were markedly lower than
that of the control, illustrating that ginsenosides as a supplement of cardioplegia may
decrease toxicity of oxygen free radicals. Infusion of St. Thomas’s Hospital solution plus
Egb761 2.5 mL/kg led to an insignificant changes of MDA content before, during and after
aortic clamping, indicating that Egb761 markedly reduce the production of lipid peroxide
during reperfusion, which may be associated with its natural anti-peroxidate property,
well-preserved myocardial energy and reduced production of hypoxanthine and xanthine (Deng
and Yu, 1999).
In general, the classification of Chinese herbal medicine according to the main
effective ingredients facilitated the expression of their functioning ways, which were proved
to be structure-sensitive. Chinese herbal drugs play an important role in cardioprotection
from many different mechanisms, with the most recent and important finding being the
inhibition of apoptosis. Further studies on Chinese herbal medicine in cardioprotective
mechanisms are needed in order to find alternative ways for the clinical management of
ischemia-reperfusion injury.
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